Compare FTRE & JBGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTRE | JBGS |
|---|---|---|
| Founded | 1996 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 829.3M | 906.3M |
| IPO Year | 2023 | 2017 |
| Metric | FTRE | JBGS |
|---|---|---|
| Price | $14.45 | $14.60 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 9 | 1 |
| Target Price | $14.06 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.5M | 536.1K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.69% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,723,400,000.00 | $498,598,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.09 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.00 | N/A |
| 52 Week Low | $3.97 | $14.03 |
| 52 Week High | $18.67 | $24.30 |
| Indicator | FTRE | JBGS |
|---|---|---|
| Relative Strength Index (RSI) | 69.40 | 42.55 |
| Support Level | $8.85 | $14.17 |
| Resistance Level | $18.26 | $16.04 |
| Average True Range (ATR) | 0.85 | 0.48 |
| MACD | 0.31 | -0.05 |
| Stochastic Oscillator | 75.65 | 11.45 |
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.